Clinical Trial Details
EORTC-21081
Back to Clinical Trials Database
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 26-Jul-2010 Date Step1 close: 02-Sep-2013 Date Step2 close: 27-Mar-2013 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 105 - All Groups: 105 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT01098656 |
| NCT number | NCT01098656 |
| EudraCT | 2009-011020-65 |
